Tuesday, 3 November 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Investor Presentation

Global Health Investor Presentation: Key Takeaways

Q2 FY27 revenue INR 14,690m (+33.6%), Operating EBITDA INR 3,701m (25.2% margin), PAT INR 2,191m (+38.3%). Volume-led growth; net cash INR 7,815m.

Highlights
Revenue growth33.6% y-o-y to INR 14,690m
MarginsOperating EBITDA margin 25.2% vs 21.0% y-o-y
Demand visibilityCensus beds 3,115 vs 2,658; occupancy 67%

Growth

IPD volumes +29.5% y-o-y; occupied bed days +22.4%; ARPP INR 2.06 lakh (+2.7%); Cluster 2 revenue +63.2%.

Outlook

Planned ~3,450 bed additions; capex INR 62,390m over 4-5 years; H2 FY27 capex INR 6,000m. No explicit growth % guidance.

Risks

No explicit risks stated; disclaimer cites macro, competition, regulatory, talent-retention factors.

Source

Investor Presentation filed with BSE, NSE: MEDANTA. Summary written with AI assistance from the document.

Read the document ↗

Global Health Ltd: key numbers

Share price
₹1,325.80
Market cap
₹35,648 Cr
Revenue (annual)
₹4,410 Cr
Net profit (annual)
₹556.5 Cr
P/E (TTM)
64.1×Sector 53.7×
Promoter holding
33.00%+0.00% QoQ
FII holding
9.92%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Global Health Ltd

All →
16:33 IST BSE
Capacity Expansion

Global Health Capacity Expansion: ₹997 Cr Investment

Medanta plans a 500-bed Ghaziabad hospital over 3-4 years. Project cost is Rs 997 Crore, funded by internal accruals and debt.

Value
₹997.0 Cr
Execution
3-4 years, phased
hospital beds
500.0 beds
16:03 IST BSE
Financial Results

Global Health Q2 FY27 Results: Net Profit ₹219.1 Cr, Up 38.3% YoY

Global Health Ltd reported revenue from operations of ₹1,469 Cr (+33.6% YoY) and net profit of ₹219.1 Cr (+38.3% YoY) for Q2 FY27.

Key figure
Net profit ₹219.1 Cr · +38.3% YoY